Andrzej Składanowski

3.5k total citations
62 papers, 2.9k citations indexed

About

Andrzej Składanowski is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Andrzej Składanowski has authored 62 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 26 papers in Oncology and 15 papers in Organic Chemistry. Recurrent topics in Andrzej Składanowski's work include Cancer therapeutics and mechanisms (40 papers), DNA Repair Mechanisms (18 papers) and DNA and Nucleic Acid Chemistry (9 papers). Andrzej Składanowski is often cited by papers focused on Cancer therapeutics and mechanisms (40 papers), DNA Repair Mechanisms (18 papers) and DNA and Nucleic Acid Chemistry (9 papers). Andrzej Składanowski collaborates with scholars based in Poland, France and United Kingdom. Andrzej Składanowski's co-authors include Annette K. Larsen, Alexandre E. Escargueil, Jerzy Konopa, Przemyslaw Bozko, Monika Podhorecka, Michał Sabisz, Józefa Węsierska‐Gądek, Krzysztof Bojanowski, Eran Bram and Yehuda G. Assaraf and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Cancer Research.

In The Last Decade

Andrzej Składanowski

62 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrzej Składanowski Poland 27 2.1k 1.1k 548 283 212 62 2.9k
Stella Tinelli Italy 27 1.6k 0.8× 1.1k 1.1× 343 0.6× 295 1.0× 359 1.7× 51 2.3k
Elisabetta Leo United Kingdom 22 2.2k 1.0× 1.1k 1.0× 362 0.7× 255 0.9× 221 1.0× 38 2.8k
Ze‐Hong Miao China 37 2.7k 1.3× 968 0.9× 888 1.6× 348 1.2× 426 2.0× 136 4.3k
Mary K. Danks United States 39 3.4k 1.6× 2.0k 1.9× 503 0.9× 249 0.9× 284 1.3× 99 5.0k
Nives Carenini Italy 27 1.4k 0.7× 934 0.9× 452 0.8× 196 0.7× 199 0.9× 62 2.1k
Thomas C. Rowe United States 24 3.2k 1.6× 1.2k 1.1× 691 1.3× 593 2.1× 299 1.4× 44 4.2k
Valentina Zuco Italy 27 1.8k 0.8× 579 0.5× 420 0.8× 176 0.6× 401 1.9× 70 2.4k
Xiongwen Zhang China 34 2.0k 0.9× 529 0.5× 364 0.7× 162 0.6× 385 1.8× 95 2.9k
Suzanne M. Cutts Australia 29 1.7k 0.8× 663 0.6× 357 0.7× 135 0.5× 184 0.9× 77 2.7k
Joseph M. Covey United States 29 2.4k 1.1× 802 0.7× 320 0.6× 347 1.2× 253 1.2× 88 3.0k

Countries citing papers authored by Andrzej Składanowski

Since Specialization
Citations

This map shows the geographic impact of Andrzej Składanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Składanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Składanowski more than expected).

Fields of papers citing papers by Andrzej Składanowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Składanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Składanowski. The network helps show where Andrzej Składanowski may publish in the future.

Co-authorship network of co-authors of Andrzej Składanowski

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej Składanowski. A scholar is included among the top collaborators of Andrzej Składanowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej Składanowski. Andrzej Składanowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wieczór, Miłosz, Grzegorz J. Grabe, Katarzyna Gucwa, et al.. (2021). Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells. International Journal of Molecular Sciences. 22(9). 4931–4931. 51 indexed citations
2.
Grabe, Grzegorz J., Marcin Serocki, Marta Świtalska, et al.. (2018). Cell Density-Dependent Cytological Stage Profile and Its Application for a Screen of Cytostatic Agents Active Toward Leukemic Stem Cells. Stem Cells and Development. 27(7). 488–513. 6 indexed citations
3.
4.
Konieczny, Marek T., et al.. (2014). Structural factors affecting affinity of cytotoxic oxathiole-fused chalcones toward tubulin. European Journal of Medicinal Chemistry. 89. 733–742. 22 indexed citations
5.
Konieczny, Marek T., et al.. (2014). Structural Factors Affecting Cytotoxic Activity of (E)‐1‐(Benzo[d ][1,3]oxathiol‐6‐yl)‐3‐phenylprop‐2‐en‐1‐one Derivatives. Chemical Biology & Drug Design. 84(1). 86–91. 11 indexed citations
6.
Węsierska‐Gądek, Józefa, et al.. (2012). PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells. Biochemical Pharmacology. 84(10). 1318–1331. 24 indexed citations
7.
Stark, Michal, Eran Bram, Patrycja Nowak‐Sliwinska, et al.. (2012). Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death and Disease. 3(4). e293–e293. 83 indexed citations
8.
Składanowski, Andrzej, Przemyslaw Bozko, Michał Sabisz, & Annette K. Larsen. (2007). Dual Inhibition of PI3K/Akt Signaling and the DNA Damage Checkpoint in p53-Deficient Cells with Strong Survival Signaling: Implications for Cancer Therapy. Cell Cycle. 6(18). 2268–2275. 20 indexed citations
9.
Wojciechowski, Marek, et al.. (2006). Interaction of antitumor triazoloacridone C-1305 and its analogs with telomeric DNA. Acta Biochimica Polonica. 53. 1 indexed citations
10.
11.
Poindessous, Virginie, et al.. (2004). The Antitumor Triazoloacridone C-1305 Is a Topoisomerase II Poison with Unusual Properties. Molecular Pharmacology. 66(4). 1035–1042. 41 indexed citations
12.
Larsen, Annette K., Alexandre E. Escargueil, & Andrzej Składanowski. (2003). From DNA damage to G2 arrest: the many roles of topoisomerase II.. PubMed. 5. 295–300. 54 indexed citations
13.
Składanowski, Andrzej. (2002). Modulation of G2 arrest enhances cell death induced by the antitumor 1-nitroacridine derivative, Nitracrine. APOPTOSIS. 7(4). 347–359. 15 indexed citations
14.
Larsen, Annette K., Alexandre E. Escargueil, & Andrzej Składanowski. (2000). Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacology & Therapeutics. 85(3). 217–229. 308 indexed citations
15.
Składanowski, Andrzej & Jerzy Konopa. (2000). Mitoxantrone and ametantrone induce interstrand cross-links in DNA of tumour cells. British Journal of Cancer. 82(7). 1300–1304. 36 indexed citations
16.
Larsen, Annette K., et al.. (1998). DNA topoisomerases as repair enzymes: mechanism(s) of action and regulation by p53.. Acta Biochimica Polonica. 45(2). 535–544. 10 indexed citations
17.
Składanowski, Andrzej, et al.. (1996). Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors.. Molecular Pharmacology. 49(5). 772–780. 64 indexed citations
18.
Larsen, Annette K., Andrzej Składanowski, & Krzysztof Bojanowski. (1996). The roles of DNA topoisomerase II during the cell cycle. PubMed. 2. 229–239. 61 indexed citations
19.
Beere, Helen M., Christine M. Chresta, Alı́ Alejo, et al.. (1995). Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis.. Molecular Pharmacology. 47(5). 986–996. 56 indexed citations
20.
Składanowski, Andrzej & Jerzy Konopa. (1994). Relevance of interstrand DNA crosslinking induced by anthracyclines for their biological activity. Biochemical Pharmacology. 47(12). 2279–2287. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stella Tinelli Breakdown of academic impact, for papers by Elisabetta Leo Breakdown of academic impact, for papers by Ze‐Hong Miao Breakdown of academic impact, for papers by Mary K. Danks Breakdown of academic impact, for papers by Nives Carenini Breakdown of academic impact, for papers by Thomas C. Rowe Breakdown of academic impact, for papers by Valentina Zuco Breakdown of academic impact, for papers by Xiongwen Zhang Breakdown of academic impact, for papers by Suzanne M. Cutts Breakdown of academic impact, for papers by Joseph M. Covey
Rankless by CCL
2026